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Abstract
Background: Fine-needle aspiration biopsy (FNA) of the abdominal fat pad is a minimally invasive 
procedure to demonstrate tissue deposits of amyloid. However, protocols to evaluate amyloid 
in fat pad aspirates are not standardized, especially for detecting scant amyloid in early disease. 
Materials and Methods: We studied abdominal fat pad aspirates from 33 randomly selected 
patients in whom subsequent tissue biopsy, autopsy, and/or medical history for confirmation of 
amyloidosis (AL) were also available. All these cases were suspected to have early AL, but had 
negative results on abdominal fat pad aspirates evaluated by polarizing microscopy of Congo Red 
stained sections (CRPM). The results with CRPM between four reviewers were compared in 12 
cases for studying inter observer reproducibility. 24 cases were also evaluated by ultrastructural 
study with electron microscopy (EM). Results: Nine of thirty-three (27%) cases reported negative 
by polarizing microscopy had amyloidosis. Reanalysis of 12 mixed positive-negative cases, showed 
considerable inter-observer variability with frequent lack of agreement between four observers 
by CRPM alone (Cohen’s Kappa index of 0.1, 95% CI -0.1 to 0.36). EM showed amyloid in the 
walls of small blood vessels in fibroadipose tissue in four out of nine cases (44%) with amyloidosis. 
Conclusion: In addition to poor inter-observer reproducibility, CRPM alone in cases with 
scant amyloid led to frequent false negative results (9 out of 9, 100%). For improved detection of 
AL, routine ultrastructural evaluation with EM of fat pad aspirates by evaluating at least 15 small 
blood vessels in the aspirated fibroadipose tissue is recommended. Given the high false negative 
rate for CRPM alone in early disease, routine reflex evaluation with EM is highly recommended 
to avert the invasive option of biopsying various organs in cases with high clinical suspicion for AL.
Key words: Cytopathology, differential diagnosis, malignant, pleural effusion, uncommon causes
INTRODUCTION
Amyloidosis (AL) comprises of a heterogeneous group 
of disorders that manifest symptoms caused by the 
extracellular deposition of misfolded insoluble proteins 
in various tissues and organs.[1,2] Classification of AL is 
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This is especially critical for detecting scant amyloid in fat 
pad aspirates from cases with early disease. In patients with 
monoclonal gammopathy, the management algorithm has 
significant clinical and economic implications if association 
of synchronous amyloidosis is not established accurately.
The objective of this study was to evaluate the utility of 
ultrastructural studies by EM to complement negative re-
sults with CRPM.[19] In addition, inter-observer variability 
in interpretation of CRPM was also evaluated.
MATERIALS AND METHODS
Abdominal fat pad aspirates from 33 randomly selected 
patients with availability of subsequent tissue biopsy, au-
topsy, and/or medical history for confirmation of AL were 
studied after approval from the institutional review board 
(IRB). All these cases had negative results on abdominal 
fat pad aspirates evaluated by CRPM.
The indication for evaluation was clinically suspected early 
AL in patients with plasma cell monoclonal gammopathy 
based on serum or urine immunofixation or serum free 
light chain assay (Freelite, The Binding Site, UK). Further 
correlation with organ biopsies, bone marrow biopsies, au-
topsies, biochemical tests, and organ response to plasma 
cell directed chemotherapy were available to evaluate the 
true rate of AL in the suspected cohort.
FNAs were performed under local anesthesia with an 
18 gauge needle by 7 cytopathologists (with 3-24 years 
experience) by the protocol reported recently as a video 
article.[20] In 24 cases, representative fibroadipose tissue 
was submitted concurrently in 10% formalin for cell block 
preparation and in glutaraldehyde fixative for EM studies. 
EM was not performed in 9 cases by some cytopatholo-
gists. The cell block preparations were made from speci-
mens received as coagulum of clotted fibroadipose tissue 
or as microfragments of fibroadipose tissue. The coagulum 
allows for easy processing for cell block preparation with 
minimal loss of diagnostic fibro fatty tissue fragments in 
the aspirated specimen with tendency to float even after 
centrifugation.[20] In cases with lack of coagulum, the 
specimens were filtered through filter paper and fibro fatty 
tissue fragments caught on the filter paper were scraped 
off for cell block preparation. All 33 cases had adequate 
aspirates for evaluation with many fibrovascular frag-
ments. Amyloid was evaluated by examining 10 µm thick, 
Congo red stained sections (not more than 1 month old) 
of formalin fixed paraffin embedded cell-blocks under 
polarized microscopy in all 33 cases [Figure 1].
Ultra-structural studies were also performed in 24 cases 
by scrutinizing the walls of at least 15 small blood ves-
sels for the presence of amyloid fibrils with diameter 
of 8-12 nµ in multiple epoxy embedded ultrathin 
based on precursor plasma proteins as well as the location 
of the deposits: Systemic versus localized, and inherited 
versus acquired.[2,3] Light chain AL (also known as primary/
immunoglobulin light chain AL) is deposition of mono-
clonal immunoglobulin light chains and accounts for the 
majority of patients with AL in the United States. The 
clinical symptomatology include proteinuria, nephrotic 
syndrome, restrictive heart failure, anemia, macroglossia, 
carpal tunnel syndrome, neuropathy, hepatomegaly, and 
other symptoms depending on the organs involved.[4] Light 
chain AL can be associated with monoclonal gammopathy 
of undetermined significance (MGUS), Waldenstrom’s 
macroglobulinemia, and lymphoplasmacytic disorders. 
It is reported in up to 15% of myeloma cases.[2,5,6]
Up to 27 distinct proteins of variable sizes, amino acid 
sequences, and structures are associated with the devel-
opment of AL.[5,6] Although several unrelated proteins 
are observed, they all produce a common beta- fibrillar 
configuration into antiparallel beta pleated sheets, which 
produce a distinct X-ray diffraction pattern with two 
characteristic signals. These insoluble polymeric fibrils 
are deposited as extracellular toxic protein aggregates 
in tissue. They are identifiable as straight, unbranching, 
randomly criss -crossing, 10-12 nµ diameter fibrils under 
electron microscopy (EM).[7] They are also identifiable by 
a characteristic apple-green birefringence under a polar-
ized microscope in Congo red stained sections (CRPM).[6]
The gold standard for tissue diagnosis of AL had been the 
biopsy of affected organs such as the kidney, liver, or heart. 
Although these biopsies have good diagnostic value, they 
are invasive at relatively higher cost with relatively frequent 
complications than fine needle aspiration biopsy (FNA). 
In the 1960s, rectal, gingival, and bone marrow biopsies 
became a common method for diagnosing amyloid as 
comparatively less invasive alternatives.[8,9] The biopsy of 
rectal mucosa, which is an easily accessible site of the GI 
tract, has a sensitivity of 80%.[8,10] Since 1973, FNA of ab-
dominal fat pad has been utilized as a minimally invasive, 
convenient, safe, economical, and simple procedure for the 
tissue diagnosis of AL.[11] This procedurally easy method 
with Congo red staining has a sensitivity of 52-88% and 
specificity greater than 95%, which, on average, was equal 
to or better than rectal biopsies.[10,12-15] However, some stud-
ies have reported lower sensitivity of fat pad aspirates with 
Congo red staining.[16] This may be due to multiple variables 
including type of patient population, severity of disease 
with scant versus abundant amyloid, experience level of 
the interpreters, microscope type, polarizer quality, room 
darkness, and time spent to detect amyloid. An additional 
limitation is the inter-observer variability in the interpreta-
tion of the fat pad aspirate with Congo red staining alone.
[9,11,13] The use of immunohistochemistry and Congo red 
fluorescence has been reported to increase the sensitivity.
[17,18] Given this variability, it is important to select appropri-
ate methods of detection and sample processing protocols. 
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sections [Figure 2]. Number of blood vessels to be evalu-
ated under EM was arbitrarily chosen as 15 blood vessels 
as all positive specimens in our study had at least 15 blood 
vessels altogether in different EM blocks from a particular 
case. The results with EM and CRPM were compared.
In order to further evaluate inter-observer reproducibility, 
Congo red stained cell block sections (not more than 1 
month old) from 4 positive cases mixed randomly with 
8 negative cases. Inter-observer reproducibility and con-
cordance for CRPM among four pathologists (without 
color blindness issues) were assessed and analyzed by 
Cohen’s kappa statistic. The post-training experience level 
of all four pathologists (2 cytopathologists and 2 surgi-
cal pathologists) ranged from 3 to 24 years. The inter 
observer reproducibility study was conducted after initial 
consensus practice session between all four pathologists.
RESULTS
CRPM alone was initially interpreted as negative in all 
the 33 cases. However, 9 out of these 33 cases (27%) 
were confirmed as having AL based on subsequent tissue 
biopsy, autopsy, and/or medical history. In 4 of these 9 
confirmed cases (44%), AL could be detected by EM of fat 
pad aspirates [Figure 3].
The results of inter observer comparison among the four pa-
thologists with CRPM showed variable sensitivity (25-75%) 
and specificity (50-100%). Kappa index of 0.1273 (95% CI 
-0.1037 to 0.3583) was consistent with poor inter-observer 
agreement between four observers for evaluation with CRPM 
alone. One of the cases with autopsy confirmed amyloid 
cardiomyopathy was positive with EM on anterior fat pad 
aspirate. This case was interpreted unequivocally as positive 
with Congo red by 3 of 4 pathologists (1 pathologist was 
equivocal) during evaluation for inter observer study. Simi-
larly, some of the unequivocally negative cases shuffled with 
positive cases were interpreted randomly as false positive by 
four interpreters. The false positive results were most likely due 
to the superficial resemblance of blue birefringence of collagen 
fibers with apple green birefringence of amyloid in Congo 
red stained sections (by 4 pathologists without color blind-
ness), especially when interpreting cases with scant amyloid.
DISCUSSION
AL is a rapidly fatal, progressive, systemic illness with 
wide spectrum of organ involvement. The median 
survival of patients with light chain AL is estimated 
at 12 months and is further decreased in the presence 
of advanced cardiac involvement.[21] Although treatment 
for light chain AL is difficult, chemotherapy and/or au-
tologous peripheral blood stem cell transplant (aimed 
at decreasing or suppressing amyloidogenic monoclonal 
proteins) are the standard of care and are effective in achiev-
ing a clonal response in 50-60% cases.[22]
Figure 2: The anterior fat pad aspirate showed amyloid (small box) in the 
wall of small blood vessels (a). The non-branching random amyloid fibrils 
with 8.6 nµ diameter were consistent with amyloid (red arrowhead) (b). 
[Epoxy embedded Glutaraldehyde fixed section, stained with uranyl acetate 
and lead citrate. Ultrastructure]
a b
Figure 1: Amyloid (red arrowheads) with orange yellow birefringence under 
polarized light. The color changes to apple green when the axis of polarizer 
(blue arrows) is changed by 90 degree (a, b). Compare with the positive 
control in c and d. [Congo red stained 10 µ sections of formalin fixed 
paraffin embedded cell block]
a
c
b
d
Figure 3: Case enrollment and results for the study to evaluate the role of 
electron microscopy and congo red stained cell block sections in detection 
of amyloid in abdominal fat pad aspirates in early amyloidosis*
CRPM Negative 
N = 33
AL (based on clinical 
features, biopsy, or 
autopsy)
N = 9
No analysis by
EM 
N=9
Positive
by EM 
N = 4
Negative
by EM 
N = 5
Negative
by EM 
N = 15
*Thirty three cases which were negative by CRPM with availability of subsequent 
tissue biopsy, autopsy, and/or medical history for confirmation of AL were selected 
randomly. Out of these 24 cases were analyzed by EM and by CRPM concurrently. 
EM was not performed in 9 cases. Out of 24 cases, 20 were negative by EM. Nine 
cases had AL amyloidosis based on clinical features, biopsy, or autopsy. Four cases 
were positive and 5 were negative by EM.
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An accurate tissue diagnosis of light chain AL is essential 
prior to chemotherapy, since the treatment is inappropriate, 
ineffective, and detrimental in other types of AL. Diagnosis of 
light chain AL involves confirmation of a clonal gammopathy 
and detection of AL in tissue. The diagnostic key step is the 
detection and confirmation of amyloid protein in tissue. 
This is usually achieved through biopsies of the abdominal 
fat pad, bone marrow, rectum, or if necessary other clinically 
involved organs such as the heart, kidney, or liver.[22] The 
abdominal fat pad aspirate serves as a simple, minimally 
invasive test in cases with clinical suspicion and helps avoid 
riskier and more invasive biopsies of affected organs.
The most frequent indication for the fat pad aspirate in this 
study was to confirm clinical suspicion of AL in patients 
with a monoclonal gammopathy established by serum/
urine immunofixation electrophoresis (IFE) or by detecting 
free light chain in serum. Compared to the direct biopsy of 
the involved organs, abdominal fat pad aspiration is safer, 
minimally invasive, less expensive, and preferred approach 
by patients and providers alike.[23] In addition, any other 
biopsy procedures including gum biopsy, rectal biopsy, 
bone marrow biopsy, or other organ biopsies may not only 
incur morbidity but add to the cost with lower sensitivity 
to detect scant amyloid in cases with early disease. This 
approach may add the cost and discomfort due to possibil-
ity of multiple attempts and repeats. Fat pad aspiration is 
inexpensive without significant morbidity.
Although CRPM is commonly used for detecting amyloid 
in the fat pad aspirates, there are several pitfalls with this 
method as highlighted by the current study. All of our 33 
cases, suspected for early disease with relatively scant amy-
loid, were negative by CRPM alone. In 9 patients with con-
firmed AL amyloidosis, additional EM with ultra-structural 
studies on fat pad aspirates detected amyloid in 4 cases (44 
%). This suggests that reflex EM should be performed in 
cases of early disease with scant amyloid. Depending on the 
approach to evaluate the specimen for amyloid, it may be 
subjected to cytology smear preparation, cell block prepara-
tion, and /or processing for electron microscopy. In a series 
of 151 patients, reported by Gertz et al., the subcutaneous 
fat aspirate was falsely negative in 28% of cases.[22] A recent 
study also reported lower sensitivity of fat pad aspiration for 
amyloid with Congo red stain.[16] Another study comparing 
EM, immuno- electron microscopy, and Congo red stain-
ing to evaluate abdominal fat pad specimens of suspected 
cardiac amyloidosis cases, reported detection of amyloid 
in 100% of cases by EM and in 93% cases by Congo red 
staining.[24] Our study on cases with early disease with scant 
amyloid could detect it in 44% (4 out of 9) cases by EM, all 
of which were negative by CRPM, thus averting subsequent 
invasive organ biopsy. Many factors including interpreter 
experience, sample adequacy, and staining techniques can 
lead to false results with CRPM of fat pad aspirates. Reflex 
testing for EM is recommended to decrease the chances of 
false negative results.
Another concern revealed by our study was the inter ob-
server variability in evaluation by CRPM of fat pad aspirates 
from cases with scant amyloid. The sensitivity (25-75%) 
and specificity (50-100%) of this technique varied widely 
between four observers. With these inconsistencies associ-
ated with application of CRPM alone, EM of abdominal fat 
pad aspirates for detection of scant amyloid in early disease 
is recommended. This may not be critical in cases with late 
stage disease with abundant amyloid deposits. Remarkably, 
44% (4 out of 9) cases of AL could be diagnosed accurately 
with EM as compared to 100% false negative results (9 out 
of 9) with CRPM alone. In addition, the false positivity due 
to superficial resemblance of focal blue birefringence associ-
ated with collagen tissue with apple green birefringence of 
amyloid may be confirmed further by EM to overcome the 
disparity related to the inter-observer variation with CRPM 
for detection of scant amyloid. Inconsistency related to the 
focal blue birefringence of collagen fibers in Congo red 
stained sections may be more challenging under routine 
surgical pathology-cytopathology setting with additional 
unanticipated factors such as color blindness and limited 
understanding of uncommonly used polarizing microscopy.
Acquisition of adequate fat pad material with enough blood 
vessels for detection of amyloid is critical. Depending on the 
gauge, needles are categorized into fine (21-25G), intermedi-
ate (18-20G), and large (e.g. - 14G).[25] The needles utilized 
for performing anterior fat pad aspiration in the reported 
literature are of variable gauges ranging from intermediate 
(18 to 20G) to fine (21 to 22G).[16] It is not uncommon to 
use wider gauge needles, such as 18G, to sample additional 
material for preparation of cell blocks during FNAB of mass 
lesions after retrieving optimum material for cytopathologic 
evaluation with fine gauge needles, such as 25G. A critical 
component of an adequate fat pad aspirate is the retrieval 
of enough material for cell block preparation and electron 
microscopy. Since cohesive fibroadipose tissue fragments do 
not aspirate well with fine needles during fat aspiration proce-
dures, wider gauge needles (such as 18G) should be preferred 
to yield adequate material.[20] Presence of just fat droplets is 
not adequate. As observed in this study, aspirate should have 
fibrovascular fragments with at least 15 blood vessels available 
for evaluation under EM. Performance of anterior fat pad FNA 
for AL with 18G needle along with triaging and processing of 
specimen including submission of the specimen for cell block 
preparation as coagulum with fibroadipose tissue was recently 
reported as an open access video article.[20]
In summary, during evaluation of fat pad aspirates, early 
AL is likely to be missed more frequently by CRPM alone 
than by a combination of CRPM and EM. The inter observer 
reproducibility for CRPM was poor with frequent false posi-
tive and false negative interpretations, especially in cohort of 
patients expected to be in early stages with scant amyloid. To 
achieve higher sensitivity and specificity in cases suspected 
for early AL, a routine EM with evaluation of at least 15 
small blood vessel walls in the aspirated fibroadipose tissue 
5CytoJournal 2011, 8:11 http://www.cytojournal.com/content//8/1/11
retrieved by FNA biopsy with 18 G needles is recommended.
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